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In the last three decades, the development of more sen-
sitive techniques used in the assessment of in vivo brain
functioning, such as computed tomography (CT) scan and
magnetic resonance imaging (MRI), has contributed to
identify cerebral changes that are either associated with
clinical features (dementia and cognitive impairment) or
described in normal subjects [1].
The presence of age-related white matter changes
(ARWMCs) is described with the increasing age and the
presence of vascular risk factors as the major determinants
for these findings [2–4], but also in subjects over 50 years old
[5].
The research of the clinical significance of ARWMC has
clearly demonstrated the association between the presence of
white matter changes and cognitive impairment, behavioural
changes, urinary disturbances, and gait diﬃculties. However,
and despite the increasing interest in this field, the interpre-
tation of the data and explanation of these mechanisms are
still under discussion.
The aim of the current special issue was to explore the
heterogeneity of the areas of impact of the ARWMC, by
including diﬀerent and less frequent approaches that allow
for a more comprehensive picture.
Focused in this general goal, we included a variety of
papers ranging from an overview of the pathophysiology,
assessment, and clinical manifestations of ARWMC, as well
as a complete revision of proposed treatments—illustrated
by the review of Y. Y. Xiong and V. Mok—to the proposal of a
mouse model of chronic cerebral hypoperfusion as a possible
tool on the explanation of the molecular pathology of white
matter lesions—presented by M. Ihara and H. Tomimoto.
With the same perspective, we included the paper of C. Sierra
et al. that presents a nice review about the relation between
hypertension and long-standing eﬀect in the cerebral white
matter. L. Yang reviewed issues related to brain plasticity and
its possible relation to age-related white matter changes, a
topic of novel interest. Also of interest is the work of A.
Xekardaki et al. that explores the use of diﬀusion tensor
imaging in bipolar disorder.
Besides the review papers, 8 original articles were
included in this special issue and are grouped in three blocks.
The first one tried to focus on the anatomical correlations
and clinical features that are related with the presence and
progression of white matter changes—cognitive changes
(memory), motor dysfunction, late-onset depression, and
health-related quality of life. E. T. Schulze et al. provided us
with an innovative approach by using multifaceted imaging
techniques on the evaluation of brain functional changes
during working memory tasks. In a less addressed field of
research,M. Viana-Baptista et al. reflected on the importance
of frontal white matter lesions for the compromise of
motor performance. J. A. Brommelhoﬀ et al. also pointed
out that late-onset depression could be a process diﬀerent
from neurodegenerative changes and describe no diﬀerences
in frontal lobe deep or subcortical white matter between
Alzheimer’s patients with or without late-onset depression.
A. M. Grool et al. discussed the relation between progression
of WMC volume and health-related quality as part of the
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large SMART Study adding data to the existing body of lit-
erature on the role of progression of white matter lesions on
decline in mental functioning in patients with symptomatic
vascular disease. A very interesting paper by V. Rajagopalan
et al. reports innovative imaging data in amyotrophic lateral
sclerosis (ALS) patients with predominant upper motor
neuron (UMN) signs.
A second section, mainly addressed to MRI analysis and
measurement of white matter changes, is represented in the
paper by S. D. Smart et al., who present the validation of
automated WMH segmentation. These authors showed that
automated segmentation of the brain provides good to very
good estimates of the volume of the aﬀected white matter,
which will enable further research into the role of ARWMC
in various diseases.
Finally, the last block of papers refers to diﬀerent basic
sciences, reflected both on the interesting paper of H. Chen
et al. that evidences reductions in fiber tract volumes and loss
of axonal neurofilaments, and on the paper by B. D. James
et al., that brought surprising findings on genetic precursors
of dementia and led us into an open discussion for possible
future directions.
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